Michael R. Shurin

Michael R. Shurin's AcademicInfluence.com Rankings

Michael R. Shurin

Physics

#7026

World Rank

#9027

Historical Rank

physics Degrees

Download Badge

Physics

Michael R. Shurin's Degrees

Bachelors Physics University of California, Berkeley
PhD Physics Stanford University

Why Is Michael R. Shurin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael R. Shurin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. (1993) (520)
Dendritic Cells in the Cancer Microenvironment (2012) (298)
Dendritic Cells in the Cancer Microenvironment (2012) (298)
Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. (2001) (242)
Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness (1994) (229)
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation (2018) (226)
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation (2018) (226)
FLT3 ligand induces the generation of functionally active dendritic cells in mice. (1997) (219)
Cyanidin-3-rutinoside, a Natural Polyphenol Antioxidant, Selectively Kills Leukemic Cells by Induction of Oxidative Stress* (2007) (218)
Current understanding of interactions between nanoparticles and the immune system. (2016) (216)
Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism1 (2009) (214)
Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism1 (2009) (214)
Th1/Th2 balance in cancer, transplantation and pregnancy (2004) (206)
Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death (2020) (198)
Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model (2013) (194)
Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model (2013) (194)
Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? (2006) (172)
Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? (2006) (172)
New flow cytometric assays for monitoring cell-mediated cytotoxicity (2010) (163)
Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations (2009) (139)
Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations (2009) (139)
Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo1 (2005) (135)
Loss of New Chemokine CXCL14 in Tumor Tissue Is Associated with Low Infiltration by Dendritic Cells (DC), while Restoration of Human CXCL14 Expression in Tumor Cells Causes Attraction of DC Both In Vitro and In Vivo1 (2005) (135)
Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms. (1995) (131)
Bone marrow‐derived dendritic cells pulsed with a tumor‐specific peptide elicit effective anti‐tumor immunity against intracranial neoplasms (1998) (130)
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner (2012) (129)
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner (2012) (129)
Tumor's other immune targets: dendritic cells (1999) (122)
Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth (2007) (122)
Low-Dose Paclitaxel Prior to Intratumoral Dendritic Cell Vaccine Modulates Intratumoral Cytokine Network and Lung Cancer Growth (2007) (122)
Dendritic cells presenting tumor antigen (1996) (120)
Tumor associated regulatory dendritic cells. (2012) (119)
Tumor associated regulatory dendritic cells. (2012) (119)
FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma. (1998) (115)
Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. (2011) (106)
Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins (2000) (106)
Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. (2011) (106)
FLT3-ligand administration inhibits liver metastases: role of NK cells. (1998) (104)
Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo. (1999) (104)
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. (2001) (100)
Inhibition of CD40 expression and CD40‐mediated dendritic cell function by tumor‐derived IL‐10 (2002) (98)
Inhibition of CD40 expression and CD40‐mediated dendritic cell function by tumor‐derived IL‐10 (2002) (98)
Tumor-derived factors modulating dendritic cell function (2016) (96)
Tumor-derived factors modulating dendritic cell function (2016) (96)
FLT3: receptor and ligand. Biology and potential clinical application. (1998) (95)
Dynamic alteration of soluble serum biomarkers in healthy aging. (2007) (94)
Dynamic alteration of soluble serum biomarkers in healthy aging. (2007) (94)
Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells (2011) (92)
Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells (2011) (92)
Myeloid regulatory cells in tumor spreading and metastasis. (2015) (91)
Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. (2006) (88)
Antigen-Processing Machinery in Human Dendritic Cells: Up-Regulation by Maturation and Down-Regulation by Tumor Cells1 (2004) (86)
Transduction of Dendritic Cells with Bcl-xL Increases Their Resistance to Prostate Cancer-Induced Apoptosis and Antitumor Effect in Mice1 (2000) (86)
Transduction of Dendritic Cells with Bcl-xL Increases Their Resistance to Prostate Cancer-Induced Apoptosis and Antitumor Effect in Mice1 (2000) (86)
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects (2021) (85)
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects (2021) (85)
Immunosuppressive Mechanisms of Regulatory Dendritic Cells in Cancer (2013) (83)
Immunosuppressive Mechanisms of Regulatory Dendritic Cells in Cancer (2013) (83)
Rapid Detection of SARS-CoV-2 Antigens Using High-Purity Semiconducting Single-Walled Carbon Nanotube-Based Field-Effect Transistors (2021) (81)
Small Rho GTPases Regulate Antigen Presentation in Dendritic Cells1 (2005) (79)
Small Rho GTPases Regulate Antigen Presentation in Dendritic Cells1 (2005) (79)
Enzymatic oxidative biodegradation of nanoparticles: Mechanisms, significance and applications. (2016) (78)
Restoration by IL-15 of MHC Class I Antigen-Processing Machinery in Human Dendritic Cells Inhibited by Tumor-Derived Gangliosides1 (2005) (76)
Restoration by IL-15 of MHC Class I Antigen-Processing Machinery in Human Dendritic Cells Inhibited by Tumor-Derived Gangliosides1 (2005) (76)
Human prostate cancer regulates generation and maturation of monocyte‐derived dendritic cells (2001) (75)
Human prostate cancer regulates generation and maturation of monocyte‐derived dendritic cells (2001) (75)
Human Small Cell Lung Carcinoma and Carcinoid Tumor Regulate Dendritic Cell Maturation and Function (2001) (73)
Human Small Cell Lung Carcinoma and Carcinoid Tumor Regulate Dendritic Cell Maturation and Function (2001) (73)
Aging and the dendritic cell system: implications for cancer. (2007) (72)
Aging and the dendritic cell system: implications for cancer. (2007) (72)
Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. (2013) (71)
Dendritic cells in cancer (2009) (71)
Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. (2013) (71)
C-reactive protein and lung diseases. (2014) (69)
C-reactive protein and lung diseases. (2014) (69)
Fibrillar vs crystalline nanocellulose pulmonary epithelial cell responses: Cytotoxicity or inflammation? (2017) (69)
ChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agents. (2012) (67)
CD154 inhibits tumor‐induced apoptosis in dendritic cells and tumor growth (1999) (65)
Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops. (2004) (65)
Antitumor activities of IL-12 and mechanisms of action. (1997) (61)
The use of dendritic cells for cancer vaccination. (1999) (60)
T-Lymphocyte Activation Increases Hypothalamic and Amygdaloid Expression of CRH mRNA and Emotional Reactivity to Novelty (1999) (59)
Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice. (2002) (59)
Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice. (2002) (59)
H1° histone and differentiation of dendritic cells. A molecular target for tumor‐derived factors (2002) (58)
Clinical evaluation of systemic and local immune responses in cancer: time for integration (2013) (56)
Biodiesel versus diesel exposure: enhanced pulmonary inflammation, oxidative stress, and differential morphological changes in the mouse lung. (2013) (56)
Regulatory dendritic cells in the tumor immunoenvironment (2012) (55)
Regulatory dendritic cells in the tumor immunoenvironment (2012) (55)
Regulatory dendritic cells: New targets for cancer immunotherapy (2011) (53)
Regulatory dendritic cells: New targets for cancer immunotherapy (2011) (53)
Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays (2008) (52)
Carbon nanotubes enhance metastatic growth of lung carcinoma via up-regulation of myeloid-derived suppressor cells. (2013) (52)
Carbon nanotubes enhance metastatic growth of lung carcinoma via up-regulation of myeloid-derived suppressor cells. (2013) (52)
Dopamine receptors in human lymphocytes: Radioligand binding and quantitative RT-PCR assays (2008) (52)
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen. (2003) (51)
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen. (2003) (51)
Graphene Oxide Attenuates Th2-Type Immune Responses, but Augments Airway Remodeling and Hyperresponsiveness in a Murine Model of Asthma (2014) (50)
Graphene Oxide Attenuates Th2-Type Immune Responses, but Augments Airway Remodeling and Hyperresponsiveness in a Murine Model of Asthma (2014) (50)
Origin and pharmacological modulation of tumor‐associated regulatory dendritic cells (2014) (49)
MDSC and TGFβ Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes. (2015) (49)
An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia (1994) (49)
Origin and pharmacological modulation of tumor‐associated regulatory dendritic cells (2014) (49)
MDSC and TGFβ Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes. (2015) (49)
Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice (2012) (48)
Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice (2012) (48)
ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials (2012) (47)
Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells (2003) (47)
Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells (2003) (47)
Targeting Myeloid-Derived Suppressor Cells in Cancer. (2017) (45)
Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells. (2010) (45)
Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells. (2010) (45)
Mechanisms of dendritic cell-induced T cell proliferation in the primary MLR assay. (2001) (44)
Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity. (2000) (43)
Tumor necrosis factor-alpha-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis. (2001) (41)
Fibrous nanocellulose, crystalline nanocellulose, carbon nanotubes, and crocidolite asbestos elicit disparate immune responses upon pharyngeal aspiration in mice (2018) (39)
Dual role of immunomodulation by anticancer chemotherapy (2013) (39)
Dendritic Cell Based Therapy of Cancer (1997) (38)
Identification of delta- and mu-type opioid receptors on human and murine dendritic cells (2001) (38)
Identification of delta- and mu-type opioid receptors on human and murine dendritic cells (2001) (38)
Low-dose Chemotherapeutic Agents Regulate Small Rho GTPase Activity in Dendritic Cells (2008) (37)
Stress-Induced Alteration of Polymorphonuclear Leukocyte Function in Rats (1994) (37)
Low-dose Chemotherapeutic Agents Regulate Small Rho GTPase Activity in Dendritic Cells (2008) (37)
Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer. (2018) (36)
Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer. (2018) (36)
Nano-Gold Corking and Enzymatic Uncorking of Carbon Nanotube Cups (2014) (35)
Effect of One or More Footshocks on Spleen and Blood Lymphocyte Proliferation in Rats (1994) (35)
Targeting myeloid regulatory cells in cancer by chemotherapeutic agents (2011) (35)
Impaired mitogen (PHA) responsiveness and increased autoantibodies in caucasian schizophrenic patients with the HLA B8/DR3 phenotype (1995) (35)
Dual acute proinflammatory and antifibrotic pulmonary effects of short palate, lung, and nasal epithelium clone-1 after exposure to carbon nanotubes. (2013) (35)
Targeting myeloid regulatory cells in cancer by chemotherapeutic agents (2011) (35)
Nano-Gold Corking and Enzymatic Uncorking of Carbon Nanotube Cups (2014) (35)
Increased function and survival of IL‐15‐transduced human dendritic cells are mediated by up‐regulation of IL‐15Rα and Bcl‐2 (2002) (34)
Increased function and survival of IL‐15‐transduced human dendritic cells are mediated by up‐regulation of IL‐15Rα and Bcl‐2 (2002) (34)
Small Rho GTPases Mediate Tumor-Induced Inhibition of Endocytic Activity of Dendritic Cells1 (2007) (34)
Small Rho GTPases Mediate Tumor-Induced Inhibition of Endocytic Activity of Dendritic Cells1 (2007) (34)
Gangliosides as immunomodulators. (2007) (33)
Human Prostate Cancer Blocks the Generation of Dendritic Cells from CD34+ Hematopoietic Progenitors (2001) (33)
The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin‐15 (1999) (33)
Human Prostate Cancer Blocks the Generation of Dendritic Cells from CD34+ Hematopoietic Progenitors (2001) (33)
Schwann cells: a new player in the tumor microenvironment (2017) (32)
Cancer as an immune-mediated disease (2012) (32)
Schwann cells: a new player in the tumor microenvironment (2017) (32)
Optimizing dendritic cell-based immunotherapy for cancer (2007) (31)
Immune-mediated diseases: where do we stand? (2007) (28)
Comparative analysis of CD1a, S-100, CD83, and CD11c human dendritic cells in normal, premalignant, and malignant tissues. (2005) (28)
Immunological monitoring of the tumor immunoenvironment for clinical trials (2012) (28)
Comparative analysis of antitumor activity of CD40L, RANKL, and 4‐1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells (2006) (27)
Impact of the Sensory Neurons on Melanoma Growth In Vivo (2016) (27)
Comparative analysis of antitumor activity of CD40L, RANKL, and 4‐1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells (2006) (27)
Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy (2015) (27)
Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy (2015) (27)
Impact of the Sensory Neurons on Melanoma Growth In Vivo (2016) (27)
Osteopontin controls immunosuppression in the tumor microenvironment (2018) (27)
The Neuroimmune Axis in the Tumor Microenvironment (2020) (26)
The Neuroimmune Axis in the Tumor Microenvironment (2020) (26)
Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth. (2019) (26)
Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth. (2019) (26)
Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow? (2010) (26)
Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening (2020) (25)
TNF-α protects dendritic cells from prostate cancer-induced apoptosis (2001) (24)
Apoptosis Induced in T Cells by Human Neuroblastoma Cells: Role of Fas Ligand (1998) (24)
Schwann cells shape the neuro-immune environs and control cancer progression (2019) (24)
In Vitro Toxicity Evaluation of Lignin-(Un)coated Cellulose Based Nanomaterials on Human A549 and THP-1 Cells. (2016) (24)
Schwann cells shape the neuro-immune environs and control cancer progression (2019) (24)
Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSA. (2007) (23)
Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSA. (2007) (23)
A new thiol-independent mechanism of epithelial host defense against Pseudomonas aeruginosa: iNOS/NO• sabotage of theft-ferroptosis (2021) (23)
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells (2009) (22)
Comparative analysis of dendritic cells transduced with different anti‐apoptotic molecules: sensitivity to tumor‐induced apoptosis (2004) (22)
Murine prostate cancer inhibits both in vivo and in vitro generation of dendritic cells from bone marrow precursors (2004) (22)
Comparative analysis of dendritic cells transduced with different anti‐apoptotic molecules: sensitivity to tumor‐induced apoptosis (2004) (22)
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells (2009) (22)
The Role of TLR4 in the Paclitaxel Effects on Neuronal Growth In Vitro (2013) (21)
The Role of TLR4 in the Paclitaxel Effects on Neuronal Growth In Vitro (2013) (21)
Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligand. (1999) (21)
Immunomodulation by Schwann cells in disease (2019) (20)
Immunomodulation by Schwann cells in disease (2019) (20)
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for Reopening (2021) (20)
Differentiation of Immunostimulatory Stem‐Cell‐ and Monocyte‐Derived Dendritic Cells Involves Maturation of Intracellular Compartments Responsible for Antigen Presentation and Secretion (2002) (19)
Effect of a conditioned aversive stimulus on the immune response in three strains of rats (1995) (18)
Nanoelectronic Discrimination of Nonmalignant and Malignant Cells Using Nanotube Field-Effect Transistors. (2017) (18)
Nanoelectronic Discrimination of Nonmalignant and Malignant Cells Using Nanotube Field-Effect Transistors. (2017) (18)
Early growth response-2 signaling mediates immunomodulatory effects of human multipotential stromal cells. (2014) (18)
Mechanistic Aspects of Stressor-Induced Immune Alteration (1994) (18)
Coagulation modifications after laparoscopic and open cholecystectomy in a swine model (1998) (17)
BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo. (2016) (16)
BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo. (2016) (16)
TNF-alpha protects dendritic cells from prostate cancer-induced apoptosis. (2001) (16)
Immune-Mediated Diseases (2007) (16)
SARS-CoV-2 serologic immune response in exogenously immunosuppressed patients (2020) (16)
Suppression of lymphocyte mitogenesis in different rat strains exposed to footshock during early diurnal and nocturnal time periods (1995) (15)
Preparation of human dendritic cells for tumor vaccination. (2003) (15)
Mediation of the single-walled carbon nanotubes induced pulmonary fibrogenic response by osteopontin and TGF-β1 (2017) (15)
Abnormal Expression of c-Myc Oncogene in NK Cells in Patients with Cancer (2019) (15)
Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications. (2015) (14)
Potentiation of E7 antisense RNA-induced antitumor immunity by co-delivery of IL-12 gene in HPV16 DNA-positive mouse tumor (1998) (14)
Alterations of oncogenes expression in NK cells in patients with cancer (2017) (14)
Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications. (2015) (14)
Regulation of dendropoiesis in cancer (1999) (14)
Immune-mediated diseases : from theory to therapy (2007) (14)
Dendritic cell based therapy of cancer. (1997) (14)
Characterization of pulmonary responses in mice to asbestos/asbestiform fibers using gene expression profiles (2018) (14)
Cancer Immunotherapy Principles and Practice (2018) (13)
Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand (2004) (13)
Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand (2004) (13)
Cytokine-based therapy for melanoma: pre-clinical studies. (2000) (13)
Immunobiology of Dendritic Cells in Cancer (2014) (13)
The Tumor Immunoenvironment (2013) (13)
Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer. (2009) (12)
NK Cells Mediate Flt3 Ligand-Induced Protection of Dendritic Cell Precursors In Vivo from the Inhibition by Prostate Carcinoma in the Murine Bone Marrow Metastasis Model (2003) (12)
Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer. (2009) (12)
NK Cells Mediate Flt3 Ligand-Induced Protection of Dendritic Cell Precursors In Vivo from the Inhibition by Prostate Carcinoma in the Murine Bone Marrow Metastasis Model (2003) (12)
Oncogenes in immune cells as potential therapeutic targets (2018) (11)
Targeting myeloid regulators by paclitaxel-loaded enzymatically degradable nanocups. (2018) (11)
Targeting myeloid regulators by paclitaxel-loaded enzymatically degradable nanocups. (2018) (11)
Assessing Immune Response to SARS-CoV-2 Infection (2020) (9)
Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22–25 April 2013, Krakow, Poland (2013) (9)
Evaluation of SARS-CoV-2 prototype serologic test in hospitalized patients (2020) (9)
Human renal cell carcinoma inhibits dendritic cell maturation and functions (2004) (9)
Cancer Therapy and Dendritic Cell Immunomodulation (2009) (9)
Dendritic Cells in Cancer: Emergenceof the Discipline (2009) (9)
Ins and Outs in Environmental and Occupational Safety Studies of Asthma and Engineered Nanomaterials. (2017) (9)
Cancer Therapy and Dendritic Cell Immunomodulation (2009) (9)
Evaluation of SARS-CoV-2 prototype serologic test in hospitalized patients (2020) (9)
Infection and Cancer: Bi-Directorial Interactions (2015) (7)
MicroRNAs are invading the tumor microenvironment: Fibroblast microRNAs regulate tumor cell motility and invasiveness (2010) (7)
CHAPTER 18 – Interleukin-15 and 21 (2003) (7)
Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy (2022) (7)
CHAPTER 18 – Interleukin-15 and 21 (2003) (7)
Effective Tumor Immunotherapy Using Bone Marrow (bm)-derived Dendritic Cells (dcs) Genetically Engineered To Express Interleukin 12 (1997) (7)
Dysregulated NF-κB–Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma (2020) (7)
Dendritic Cells in the Tumor Microenvironment (2016) (6)
P. aeruginosa augments irradiation injury via 15-lipoxygenase–catalyzed generation of 15-HpETE-PE and induction of theft-ferroptosis (2022) (6)
Notch signaling defects in NK cells in patients with cancer (2020) (6)
New perspectives in cancer immunotherapy and immunomonitoring. (2009) (6)
Notch signaling defects in NK cells in patients with cancer (2020) (6)
GENERATION OF HUMAN DENDRITIC CELLS FROM CD34+ PRECURSORS FOR HUMAN CLINICAL TRIALS (1997) (5)
A Cross-Sectional Study of SARS-CoV-2 Seroprevalence between Fall 2020 and February 2021 in Allegheny County, Western Pennsylvania, USA (2021) (5)
Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. (2019) (5)
Racial Differences in S100b Levels in Persons with Schizophrenia (2019) (5)
Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. (2019) (5)
Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies (2021) (5)
Racial Differences in S100b Levels in Persons with Schizophrenia (2019) (5)
Antibody Responses in Elderly Residential Care Persons following COVID-19 mRNA Vaccination (2021) (5)
Regulation of Carcinogenesis by Sensory Neurons and Neuromediators (2022) (5)
Inactivation of RIP3 kinase sensitizes to 15LOX/PEBP1-mediated ferroptotic death (2022) (5)
Regulation of Carcinogenesis by Sensory Neurons and Neuromediators (2022) (5)
TUMORS INDUCE APOPTOSIS OF DENDRITIC CELLS IN VITRO. (1997) (5)
Neuroimmune Regulation of Surgery-Associated Metastases (2021) (4)
Differences in dendritic cell activation and distribution after intravenous, intraperitoneal, and subcutaneous injection of lymphoma cells in mice. (2007) (4)
Tumor Innervation: History, Methodologies, and Significance (2022) (4)
Incidence and Management of Therapeutic Monoclonal Antibody Interference in Monoclonal Gammopathy Monitoring. (2019) (4)
Chapter 12 – Immunoglobulin Titers and Immunoglobulin Subtypes (2005) (4)
Sensory nerves impede the formation of tertiary lymphoid structures and development of protective anti-melanoma immune responses. (2022) (4)
FLT3-LIGAND INHIBITS TUMOR PROGRESSION IN MURINE MODEL (1996) (4)
A Carbon Nanotube Sensor Array for the Label-Free Discrimination of Live and Dead Cells with Machine Learning. (2022) (4)
Tumor Innervation: History, Methodologies, and Significance (2022) (4)
Neuroimmune Regulation of Surgery-Associated Metastases (2021) (4)
Sensory nerves impede the formation of tertiary lymphoid structures and development of protective anti-melanoma immune responses. (2022) (4)
A Carbon Nanotube Sensor Array for the Label-Free Discrimination of Live and Dead Cells with Machine Learning. (2022) (4)
Bacterial Infections and Cancer Development (2015) (4)
Respiratory System, Part Two: Allergy and Asthma (2017) (3)
Immunological targets for cancer therapy: new recognition (2018) (3)
A Novel Approach to Remove Interference of Therapeutic Monoclonal Antibody with Serum Protein Electrophoresis. (2019) (3)
Third Successful Pregnancy and Delivery in a Patient with Permanent Junctional Reciprocating Tachycardia (1995) (3)
Respiratory System, Part Two: Allergy and Asthma (2017) (3)
IL-12-Dependent Mechanism Presentation by Dendritic Cells via an Concentrations Increase Antigen Chemotherapeutic Agents in Noncytotoxic (2009) (3)
Immune-Mediated Diseases II Congress: Summary (2008) (3)
Role of the Immunological Environment in Cancer Initiation, Development and Progression (2013) (3)
IL-12-Dependent Mechanism Presentation by Dendritic Cells via an Concentrations Increase Antigen Chemotherapeutic Agents in Noncytotoxic (2009) (3)
NEUTROPHIL GRANULE PEPTIDES DEFENSINS INDUCE DEVELOPMENT OF MATURE DENDRITIC CELLD FROM HUMAN CD34+ STEM CELLS (1999) (3)
Nitrogen-Doped Carbon Nanotube Cups for Cancer Therapy. (2021) (2)
Conference Scene: Immunotherapy reaches new milestones in cancer eradication. (2011) (2)
Resolving Transferrin Isoforms via Agarose Gel Electrophoresis. (2015) (2)
Nitrogen-Doped Carbon Nanotube Cups for Cancer Therapy. (2021) (2)
Tumor-Induced T Cell Polarization by Schwann Cells (2022) (2)
IMPACT OF TUMOR-DERIVED FACTORS ON DENDRITIC CELLS IN CANCER (2017) (2)
Alpha, beta, gamma of serum proteins: a long history of successfully resolved problems (2017) (2)
Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): Moving forward (2012) (2)
CREATING IMMUNE PRIVILEGE: NEUROBLASTOMA SOLUBLE FACTORS CAUSE APOPTOSIS OF FAS-SENSITIVE TARGETS (1997) (2)
Cancer and infection: friends or foes? (2012) (2)
Generation In Vivo and FLT 3 Ligand on Dendritic Cell Effect of Vascular Endothelial Growth Factor (1999) (2)
Tumor-Induced T Cell Polarization by Schwann Cells (2022) (2)
584: PSA-Induced Inhibition of Dendropoiesis in Prostate Cancer (2004) (1)
Analysis of Myeloid-Derived Suppressor Cells in Patients with Cancer (2013) (1)
FLT 3-Ligand Administration Inhibits Liver Metastases : Role of NK Cells 1 (1998) (1)
Tumor infiltrating dendritic cells (DC) in prostate cancer (PCa): Implications for vaccine therapy (2005) (1)
Immune-mediated diseases: from theory to therapy. 10-15 September 2007, Moscow, Russia. (2007) (1)
IL-12 AND FLT3 LIGAND DIFFERENTIALLY STIMULATE LYMPHOID AND MYELOID DENDROPOIESIS IN VIVO. (1997) (1)
Prostate cancer suppresses dendropoiesis both in vitro and in vivo (2002) (1)
Inhibition of ganglioside synthesis abrogrates neuroblastoma mediated lymphocyte apoptosis1 (1999) (1)
Cerebrospinal Fluid Leak Detection with a Carbon Nanotube-Based Field-Effect Transistor Biosensing Platform. (2021) (1)
Evaluation of the Tumor Immunoenvironment in Clinical Trials (2013) (1)
Cancer Immunotherapy and Immunomonitoring (CITIM): Redefining Cancer Therapy (2009) (1)
Malfunction of the Dendritic Cell System in Cancer (2004) (1)
Malfunction of the Dendritic Cell System in Cancer (2004) (1)
FLT 3 Ligand Administration Inhibits Tumor Growth in Murine Melanoma and Lymphoma 1 (2006) (1)
Infection and Cancer: Multi-directorial Relationship (2015) (1)
Cerebrospinal Fluid Leak Detection with a Carbon Nanotube-Based Field-Effect Transistor Biosensing Platform. (2021) (1)
Prostate cancer suppresses dendropoiesis both in vitro and in vivo (2002) (1)
CellsMaturation and Down-Regulation by Tumor Dendritic Cells: Up-Regulation by Antigen-Processing Machinery in Human (2004) (1)
PROTECTION OF HUMAN DENDRITIC CELLS FROM PROSTATE CANCER-INDUCED APOPTOSIS BY IL-12 AND IL-15 (1999) (1)
Analysis of Myeloid-Derived Suppressor Cells in Patients with Cancer (2013) (1)
584: PSA-Induced Inhibition of Dendropoiesis in Prostate Cancer (2004) (1)
Tumor infiltrating dendritic cells (DC) in prostate cancer (PCa): Implications for vaccine therapy (2005) (1)
Cancer-associated Molecular Abnormalities in Human NK cells (2021) (1)
Low-Dose Chemomodulation and Cancer Vaccines (2014) (0)
PATHOPHYSIOLOGY OF DENDRITIC CELLS IN CANCER (2016) (0)
Basic and Clinical Immunology by Names: From the Biblical Time Until the Present (2023) (0)
A Novel Therapeutic Target for Small-Cell Lung Cancer: Tumor-Associated Repair-like Schwann Cells (2022) (0)
Inhibition of the dendritic cell system in prostate cancer is mediated by a deficient CD40 ligation (2003) (0)
TITLE: Epigenetic Regulation of Chermokine Expression in Prostate Cancer (2008) (0)
ff ects of Carbon Nanotubes on Dendritic Cells Induce Immune Suppression Upon Pulmonary Exposure (2011) (0)
Abstract 3375: Can prostate cancer derived neuromodulators regulate intratumoral axonogenesis (2015) (0)
ChemoImmunoModulation: Focus on Myeloid Regulatory Cells (2013) (0)
Cellsof Endocytic Activity of Dendritic Small Rho GTPases Mediate Tumor-Induced (2013) (0)
Epigenetic Regulation of Chermokine Expression in Prostate Cancer (2008) (0)
Dendritic cells function and survival are dependent on endothelin-1 and endothelin receptors autocrine loops (2004) (0)
Expression of Pu.1, C/Ebp? and Bach1 Transcription Factors in Immune Cells in Patients with Cancer (2021) (0)
Redox phospholipidomics discovers pro-ferroptotic death signals in A375 melanoma cells in vitro and in vivo (2023) (0)
Pharmacological regulation of the tumor immuno environment (2015) (0)
Ointment comprising phosphatidylserine as active agent for cancer treatment (2007) (0)
Effect in Mice Cancer-Induced Apoptosis and Antitumor Increases Their Resistance to Prostate L Transduction of Dendritic Cells with Bcl-x (0)
Comorbid Development of Infection and Cancer (2015) (0)
[The effect of dalargin on stress-induced changes in the 5'-nucleotidase activity of the macrophages and in the level of endogenous blood cortisol in mice]. (1992) (0)
Comprar Dendritic Cells in Cancer | Shurin, Michael R. | 9780387886107 | Springer (2009) (0)
Inhibition of Endocytic Activity of Dendritic Small Rho GTPases Mediate Tumor-Induced (2007) (0)
FUNCTIONAL FAS LIGAND IS EXPRESSED ON NEUROBLASTOMA AND HEPATOBLASTOMA CELLS (1997) (0)
ImmunoTargets and Therapy Cancer as an immune-mediated disease (2012) (0)
Epigenetic Regulation of Chemokine Expression in Prostate Cancer (2006) (0)
Comprar Immune Mediated Diseases: From Theory to Therapy | Shurin, Michael R. | 9780387720043 | Springer (2007) (0)
Dendritic Cells Inhibited by Tumor-Derived Antigen-Processing Machinery in Human Restoration by IL-15 of MHC Class I (2017) (0)
Evidence for an autoimmune pathogenesis in a subgroup of schizophrenic patients (1993) (0)
Nanomaterials in tumor immunology: Friends or foes? (2016) (0)
Modulation of regulatory dendritic cell polarization in cancer by paclitaxel. (2012) (0)
Decreased PHA stimulated IL-2 production in drug-naive schizophrenics (1994) (0)
VivoCauses Attraction of DC Both In Vitro and In Human CXCL14 Expression in Tumor Cells Dendritic Cells (DC), while Restoration of Tissue Is Associated with Low Infiltration by Loss of New Chemokine CXCL14 in Tumor (2005) (0)
Gangliosides Dendritic Cells Inhibited by Tumor-Derived Antigen-Processing Machinery in Human Restoration by IL-15 of MHC Class (2005) (0)
Inhibition of the dendritic cell system in prostate cancer is mediated by a deficient CD40 ligation (2003) (0)
Expression of Pu.1, C/Ebp? and Bach1 Transcription Factors in Immune Cells in Patients with Cancer (2021) (0)
Alterations in cytokine production and chemokine receptor expression in dendritic cells in elderly cancer patients (2005) (0)
Investigations into the Influence of Chronic Colitis on Colonic Adenocarcinoma Cell Growth "A Progress Report" (2017) (0)
Tixagevimab Plus Cilgavimab Does Not Affect the Interpretation of Electrophoretic and Free Light Chain Assays. (2022) (0)
Basic and Clinical Immunology by Names: From the Biblical Time Until the Present (2023) (0)
Characterization of antigen-processing machinery in human monocyte-derived immature and mature dendritic cells (2004) (0)
ff ects of Carbon Nanotubes on Dendritic Cells Induce Immune Suppression Upon Pulmonary Exposure (2011) (0)
TITLE : Epigenetic Regulation of Chemokine Expression in Prostate Cancer PRINCIPAL INVESTIGATOR : (2006) (0)
endothelin receptor autocrine loops Function and survival of dendritic cells depend on endothelin-1 and (2013) (0)
Chapter 9 – Handling Sera and Obtaining Fluid from Different Compartments: Practical Considerations (2005) (0)
This information is current as Spontaneous Melanoma Model Cells and Chronic Inflammation in the Inhibition of Myeloid-Derived Suppressor Antitumor Effect of Paclitaxel Is Mediated by (2013) (0)
ADMINISTRATION OF IL-12 AND FL T3 LIGAND ENHANCES MURINE DENDRITIC CELL GENERATION (1997) (0)
Modulation of regulatory dendritic cell polarization in cancer by paclitaxel. (2012) (0)
COVID-19 mRNA Vaccines May Cause False Reactivity in Some Serologic Laboratory Tests, Including Rapid Plasma Reagin Tests (2022) (0)
VivoCauses Attraction of DC Both In Vitro and In Human CXCL14 Expression in Tumor Cells Dendritic Cells (DC), while Restoration of Tissue Is Associated with Low Infiltration by Loss of New Chemokine CXCL14 in Tumor (2005) (0)
Redefining cancer immunotherapy—optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27–30, 2015, Ljubljana, Slovenia (2016) (0)
Daratumumab Interference With Serum Protein Electrophoresis: 34 (2018) (0)
Murine and human melanoma induces apoptosis of dendritic cells: A potential mechanism of tumor-induced immunosuppression (1998) (0)
New Syphilis Serology Testing Requires New Reporting Algorithms. (2020) (0)
Abstract 3375: Can prostate cancer derived neuromodulators regulate intratumoral axonogenesis (2015) (0)
Effect of dalargin of stress-induced change in macrophagal 5′-nucleotidase activity and endogenous cortisol level in mouse blood (1992) (0)
Dendritic Cells Inhibited by Tumor-Derived Antigen-Processing Machinery in Human Restoration by IL-15 of MHC Class I (2017) (0)
AUTHOR PROOF COPY Not for publication (2012) (0)
Gangliosides Dendritic Cells Inhibited by Tumor-Derived Antigen-Processing Machinery in Human Restoration by IL-15 of MHC Class (2005) (0)
Subject Index Vol. 16, 1998 (2000) (0)
Effect in Mice Cancer-Induced Apoptosis and Antitumor Increases Their Resistance to Prostate L Transduction of Dendritic Cells with Bcl-x (0)
Ointment comprising phosphatidylserine as active agent for cancer treatment (2007) (0)
INTERLEUKIN-10 EFFECTS ON IN VIVO GENERATION AND IN VITRO FUNCTION OF DENDRITIC CELLS (1996) (0)
Pediatric Hypereosinophilia, Liver Disfunction, and Hemolytic Anemia with Autoimmune Differential. (2020) (0)
Alterations in cytokine production and chemokine receptor expression in dendritic cells in elderly cancer patients (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael R. Shurin?

Michael R. Shurin is affiliated with the following schools: